Avricore Health (AVCRF) Convertible Debt (2013 - 2014)

Avricore Health (AVCRF) posted quarterly Convertible Debt of $15163.7 for Q3 2014, down 49.83% sequentially from $30225.9 in Q2 2014.

Avricore Health (AVCRF) Convertible Debt (2013 - 2014) Analysis & Trends

Avricore Health has disclosed Convertible Debt across 1 years of filings, most recently posting $15163.7 for Q3 2014.

In Q3 2014, Convertible Debt changed N/A year-over-year to $15163.7; the TTM figure through Sep 2014 stood at $15163.7 (changed N/A YoY), while the FY2014 annual figure was $30840.1, changed N/A from the prior year.
Convertible Debt declined to $15163.7 in Q3 2014, from $30225.9 in the prior quarter.
Over the last five years, Convertible Debt for AVCRF reached as high as $30225.9 in Q2 2014 and fell as low as $15163.7 in Q3 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Waters	31,055.11 Bn	31,054.65 Bn	1.11 Bn
2	Thermo Fisher Scientific	191.02 Bn	187.77 Bn	7.74 Bn
3	Danaher	137.16 Bn	131.47 Bn	3.59 Bn
4	Idexx Laboratories	42.82 Bn	42.62 Bn	722.74 Mn
5	Natera	39.09 Bn	37.99 Bn	696.04 Mn
6	Agilent Technologies	37.61 Bn	35.81 Bn	990.00 Mn
7	Iqvia Holdings	34.23 Bn	32.25 Bn	1.36 Bn
8	Illumina	28.14 Bn	26.98 Bn	721.00 Mn
9	Mettler Toledo International	26.40 Bn	26.33 Bn	555.82 Mn
10	Avricore Health	-	-	-

Download Data